
ABSTRACT Isolated T3 toxicosis has a prevalence of 8.5% in the Indian population and poses therapeutic challenges due to the risk of iatrogenic hypothyroidism, even with low-dose antithyroid drugs. Management becomes more complex in cases with discordant thyroid function tests, particularly low T4 with elevated T3, requiring cautious dose titration to prevent further T4 suppression. We report a case of long-standing poorly controlled Graves’ disease with prior failure of radioiodine ablation, presenting with dysphagia and thyrotoxic symptoms. Thyroid profile showed low T4 and elevated T3 levels despite Carbimazole 40 mg/day. Given the discordance, block-and-replacement therapy was initiated to address both T3 excess and T4 deficiency. With serial titration, euthyroidism was achieved, allowing for definitive total thyroidectomy. The patient is currently stable on levothyroxine 100 mcg/day. Block-and-replacement therapy can serve as an effective bridge in such complex cases before surgery.
ABSTRACT Thyroid disorders in children represent a common and usually treatable endocrine disorder. Anemia in children is another prevalent illness that can present in a variety of ways, ranging from mild and asymptomatic to more severe types with obvious symptoms. Moreover, anemia is a frequent, although often underestimated, clinical problem accompanying thyroid diseases and constitutes an important clinical issue. Anemia has been documented in 20%–60% of hypothyroid children and 33% of cases of Graves’ disease (GD). On the other hand, iron deficiency anemia (IDA) and thalassemia major can be associated with impaired thyroid function, particularly hypothyroidism. The causative relationship between both disorders appears to be complex and occasionally unclear. This article offers a thorough summary of the relationship and reciprocal impact of anemia and thyroid problems in children. It is important for the clinician to evaluate thyroid status in children with anemia and vice versa, considering the possible connection between thyroid problems and anemia. Adequate correction of the anemia and early identification and treatment of thyroid dysfunction are essential to significantly improve clinical outcomes of these children.
ABSTRACT Thyroid storm (TS) or thyrotoxic crisis is a rare medical emergency that may initially present with various clinical manifestations including nausea, palpitations, and fever. Although quite unusual, TS may also clinically present with neurological manifestations of agitation, delirium and anxiety as well as ophthalmological manifestations, including proptosis and eyelid lag. A detailed literature review of case reports and various studies has reported nystagmus to be an extremely rare initial clinical manifestation of TS. We report a case of a young female, newly diagnosed with hyperthyroidism, who primarily presented with complaints of isolated nystagmus. She was diagnosed with TS and immediately started on medications. Her nystagmus improved once she was treated for TS. In conclusion, nystagmus as a manifestation of TS is an unusual phenomenon but can be reversible with appropriate treatment of the underlying cause.
ABSTRACT Subclinical hypothyroidism (SCH), defined by elevated thyroid-stimulating hormone with normal free thyroxine, is traditionally regarded as a clinically silent and benign endocrine state. This assumption, however, is increasingly challenged in psychiatric populations, where even subtle neuroendocrine disturbances may exert significant effects on mood regulation, cognition, stress responsivity, and suicidal behavior. Individuals with mental illness represent a biologically vulnerable group characterized by hypothalamic–pituitary–adrenal axis dysregulation, systemic inflammation, circadian disruption, autoimmune activation, and exposure to psychotropic medications, factors that may amplify the neuropsychiatric impact of mild thyroid dysfunction. Emerging epidemiological and clinical evidence links SCH and autoimmune thyroid disease with depression severity, treatment resistance, and increased suicidal behavior, particularly among adolescents and young adults. In India, where thyroid disorders are highly prevalent and suicide remains a major public health concern, thyroid reference intervals are largely derived from Western populations and are not validated against psychiatric outcomes. This viewpoint argues that SCH is not clinically silent in psychiatric illness and proposes a shift from population-based laboratory cutoffs toward outcome-anchored, context-specific thyroid interpretation. Recalibrating thyroid assessment using suicidality and psychiatric severity as meaningful endpoints may enhance early biological risk detection, support precision psychiatry, and contribute to suicide prevention strategies in resource-constrained settings.